本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

28.36
+0.79002.87%
成交量:98.28万
成交额:2,769.68万
市值:35.82亿
市盈率:-15.54
高:28.43
开:27.54
低:27.14
收:27.57
52周最高:41.94
52周最低:16.10
股本:1.26亿
流通股本:7,811.99万
量比:0.97
换手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):-1.8245
每股收益(LYR):-1.5970
净资产收益率:-108.49%
总资产收益率:-13.77%
市净率:22.91
市盈率(LYR):-17.76

数据加载中...

2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities